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Abstract A mouse cDNA that encodes a DNA-binding protein
was identified by yeast two-hybrid screening, using activating
transcription factor-2 (ATF-2) as the bait. The protein contained
a bZIP (basic amino acid-leucine zipper region) domain and its
amino acid sequence was almost identical to that of rat Jun
dimerization protein 2 (JDP2). Mouse JDP2 interacted with
ATF-2 both in vitro and in vivo via its bZIP domain. It was
encoded by a single gene and various transcripts were expressed
in all tested tissues of adult mice, as well as in embryos, albeit at
different levels in various tissues. Furthermore, mouse JDP2
bound to the cAMP-response element (CRE) as a homodimer or
as a heterodimer with ATF-2, and repressed CRE-dependent
transcription that was mediated by ATF-2. JDP2 was identified
as a novel repressor protein that affects ATF-2-mediated
transcription. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
Key words: Activating transcription factor-2; Transcription
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1. Introduction
Activating transcription factor-2 (ATF-2) is a member of
the ATF/CREB family of transcription factors. It contains a
basic amino acid-leucine zipper motif (bZIP) and mediates a
variety of transcriptional responses that are associated with
the proliferation and di¡erentiation of cells, tumorigenesis
and apoptosis [1^6]. ATF-2 forms homodimers and hetero-
dimers with other members of the ATF family, as well as
with members of the Jun/Fos family, through the leucine zip-
per motif [7^14]. Furthermore, it binds to the cAMP-response
element (CRE) and to CRE-like elements [3^5].
It has been proposed that each homo- or heterodimer that
includes ATF-2 is functionally unique in terms of the capacity
to regulate transcription and ability to target a particular
subset of CRE/ATF- or Ap-1-regulated genes [11]. ATF-2
has been implicated as a mediator in the transcriptional re-
sponse to the adenovirus E1A protein [3^5], the Rb protein
[12] and genotoxic stress [13]. However, the biological role of
ATF-2 is poorly understood. ATF-2 knockout mice exhibit
reduced postnatal viability and growth, with a defect in endo-
chondral ossi¢cation and ataxia, that is accompanied by de-
creases in the number of cerebellar Purkinje cells [14], and
symptoms of severe respiratory distress, which resemble those
of severe human meconium aspiration syndrome [15].
The transactivation capacity of ATF-2 is also regulated by
phosphorylation, which is catalyzed, in part, by the Jun ami-
no-terminal kinase/stress-activated protein kinase (JNK/
SAPK) and by mitogen-activated protein kinases in the p38
family, in response to cellular stress [13,16^18]. SAPKs, such
as JNKs and p38, phosphorylate ATF-2 at residues Thr-69,
Thr-71 and Ser-90, which are located close to the amino-ter-
minal transcriptional activation domain. This phosphoryla-
tion stimulates the transactivating capacity of ATF-2 [18].
The conserved region 3 (CR3) of adenovirus E1A protein
interacts with the leucine zipper of ATF-2, putatively inducing
a conformational change that results in exposure of the ami-
no-terminal activation domain [19]. This type of activation
involves the phosphorylation of threonine or serine residues
in the amino-terminal region of ATF-2. The E1A protein can
also activate transcription of the c-jun gene in a CR1-depen-
dent manner. This activation is mediated by two Ap-1/ATF-
like elements in promoters, namely, jun1-TRE (TGACATCA)
and jun2-TRE (TTACCTCA), which preferentially bind het-
erodimers composed of pre-existing c-Jun and ATF-2 or an
ATF-2-related factor [13,20]. Activation that is dependent on
CR1 does not depend strictly on the presence of Thr-69 and
Thr-71 at the amino-terminus of ATF-2 [19]. The mechanism
of the CR1-dependent activation of the c-jun gene, that is
mediated by ATF-2, is still unclear.
We have shown that ATF-2 and p300 cooperate in retinoic
acid (RA)-mediated and in E1A-mediated transcription of the
c-jun gene during the di¡erentiation of mouse embryonal car-
cinoma F9 cells [21^23]. We also found that phosphorylation
of p300 and of ATF-2 is associated with the RA- and the
E1A-mediated di¡erentiation of F9 cells. We identi¢ed two
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complexes, designated di¡erentiation regulatory factor-1
(DRF1) and DRF2, that bound speci¢cally to a di¡erentia-
tion-response element, which was both necessary and su⁄-
cient for the RA- and the E1A-mediated enhancement of
the expression of the c-jun gene [24]. However, the level of
transactivation of the c-jun promoter by p300 and ATF-2 was
consistently lower than the level achieved during RA- and
during E1A-dependent activation of the c-jun gene. UV
cross-linking studies also indicated the presence of other pro-
teins in the DRF complexes [21]. Therefore, in this study, in
an attempt to identify other proteins in the DRF complexes
during the di¡erentiation of F9 cells, we used a yeast two-
hybrid assay with ATF-2 as the bait. We describe here the
identi¢cation of mouse Jun dimerization protein 2 (JDP2) as a
direct partner of ATF-2, that represses the CRE-dependent
transcription mediated by ATF-2.
2. Materials and methods
2.1. Plasmids
pGBT9-ATF-2, which included the full-length cDNA for ATF-2
fused to the GAL4 DNA-binding domain (GAL4DBD), was prepared
as described elsewhere [25]. pGEX-ATF-2 and pECE-ATF-2 were
gifts from M. Green (University of Massachusetts Medical Center,
Worcester, MA, USA). pGEX-JDP2 was generated by ligating the
PCR-ampli¢ed fragment of DNA that included the coding sequence
(amino acids 1^163) of JDP2 into pGEX-4T-1 (Amersham Pharmacia
Biotech., Buckinghamshire, UK), in frame. CRE/tk-CAT was pro-
vided by M.R. Montiminy (Salk Institute, La Jolla, CA, USA) [26].
mCRE/tk-CAT was constructed using site-directed mutagenesis to
change the CRE site (5P-TGACGTCA-3P) into an mCRE site (5P-
TGCAGTCA-3P). pcDNA4-JDP2 was prepared by subcloning the
JDP2-coding region, which had been ampli¢ed by PCR, into
pcDNA4/HisMax (Invitrogen Co., Carlsbad, CA, USA). pBluescript
(pBS)-ATF-2bZIP and pGEX-JDP2bZIP were generated by inserting
the bZIP DNA fragment of ATF-2 (amino acids 350^415) or of JDP2
(amino acids 70^135), respectively, into the appropriate site of the
pBS and the pGEX vector. pGEX-JDP2bZIP(L34V) was also con-
structed by site-directed mutagenesis in which the third and the fourth
leucine in the bZIP region of JDP2 were converted to valine.
2.2. Yeast two-hybrid screening
Yeast two-hybrid screening was carried out according to the man-
ufacturer’s instructions (Clontech Inc., Palo Alto, CA, USA). Yeast
strain HF7C, which included both HIS3 and LacZ reporter genes
under the control of the GAL4 upstream activating sequence
(UAS), was cotransformed with the bait plasmid pGBT9-ATF-2
and with a mouse 11-day embryo MATCHMAKER1 cDNA library
constructed in pACT2 (Clontech Inc.) with inserts fused to the GAL4
activation domain (GAL4AD). Transformants were grown in selective
medium without tryptophan (Trp; pGBT9-speci¢c selective marker),
leucine (Leu; pACT2-speci¢c selective marker) and histidine (His;
speci¢c for the reporter) at 30‡C. Colonies that both expressed the
HIS3 reporter as a result of interaction of two-hybrid proteins, and
grew in this selection medium were further analyzed for L-galactosi-
dase activity due to the LacZ derived from the corresponding report-
er. The plasmids from His/L-galactosidase colonies were then used
to transform Escherichia coli HB101 by electroporation. The trans-
formants were grown on M9 (3Leu) media for selection of colonies
that contained pACT2. Then the plasmids were puri¢ed and cDNA
inserts were sequenced. To de¢ne the unknown sequences at the 5P-
ends of the cDNAs from clones isolated by the two-hybrid screening
assay, we performed 5P-rapid ampli¢cation of cDNA ends (RACE)
using a Marathon1 cDNA ampli¢cation kit (Clonetech Inc.) in ac-
cordance with the manufacturer’s protocol. Poly(A) RNA was puri-
¢ed from F9 cells with a ‘Quick prep. micro puri¢cation’ kit (Amer-
sham Pharmacia Biotech.). The sequence of the speci¢c primer for 5P-
RACE was 5P-AGTTTGTCACGTGCCTGGGAGGGGC-3P.
2.3. Translation in vitro and examination of the binding of ATF-2 and
JDP2
In vitro transcription/translation of pBS-ATF-2, pBS-JDP2 or pBS-
ATF-2bZIP was performed with a kit from Promega (Madison, WI,
USA) according to the manufacturer’s protocol. Plasmids were tran-
scribed with T3/T7 RNA polymerase and proteins were translated in
reticulocyte lysates in the presence of [35S]methionine. The e⁄ciency
of translation was monitored by sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE). Proteins were quantitated
with a Bio-Imaging Analyzer (BAS 2000; Fuji, Tokyo, Japan). For
protein-binding assays, 2 Wg of GST fusion protein, that included
JDP2, ATF-2, JDP2bZIP or JDP2bZIP(L34V), was mixed with 5 Wl
of reticulocyte lysate, together with glutathione-Sepharose beads
(Amersham Pharmacia Biotech.), for 2 h at 4‡C. The beads were
then washed extensively and protein complexes were eluted with bu¡-
er containing 10 mM glutathione for analysis by SDS^PAGE. Gels
were dried prior to exposure to X-ray ¢lm.
2.4. Binding of ATF-2 and JDP2 in vivo
Nuclear extracts of F9 cells, which had been transfected with the
plasmid for ATF-2 together with either the plasmid for histidine-
tagged JDP2 or the empty vector alone using FuGENE61 transfec-
tion reagent (Boehringer Mannheim, Mannheim, Germany), were in-
cubated with TALON metal a⁄nity resins (Clonetech Inc.) for 30 min
at 4‡C. The resins were then washed extensively and the bound pro-
teins were eluted with the bu¡er containing 50 mM imidazole for 20
min at room temperature. The samples were resolved on 10% SDS
gels and subjected to Western blot analysis with anti-ATF-2 antibody
(Santa Cruz Biotech. Inc., Santa Cruz, CA, USA).
2.5. Northern blotting analysis
A mouse multiple-tissue Northern (MTN) blot prepared with poly-
(A) RNA from eight di¡erent mouse tissues and mouse embryonic
MTN blot prepared with poly(A) RNA from di¡erent embryo tis-
sues were obtained from Clonetech Inc. and hybridizations were per-
formed according to the manufacturer’s instructions. The probe was
radiolabeled with [K-32P]dCTP by the random-priming method of
Feinberg and Vogelstein [27,28].
2.6. Culture and transfection of cells and assay of CAT activity
NIH3T3 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
that had been supplemented with 10% fetal bovine serum (Gibco-
BRL, Rockville, MD, USA). Cells were transfected with plasmid
DNA using the FuGENE61 transfection reagent according to the
manufacturer’s protocol. Cells were harvested 24 h after transfection
and assays of CAT activity were performed as described elsewhere
[24]. The extent of conversion of chloramphenicol to its acetylated
forms was determined with the Bio-Imaging analyzer. The ratio of
CAT activity to that of L-galactosidase was used for normalization
of results.
2.7. Electrophoretic mobility shift assay (EMSA)
Plasmids pGEX-ATF-2, pGEX-JDP2 and pGEX were used to gen-
erate GST-ATF-2, GST-JDP2 and glutathione S-transferase (GST)
and the proteins were puri¢ed as described elsewhere [21]. The pro-
teins in various combinations were incubated in binding bu¡er (20
mM Tris (pH 7.5), 2 mM MgCl2, 0.5 mM EDTA, 10% glycerol, 0.5
mM dithiothreitol, 25 mM NaCl, 0.5 Wg poly(dI-dC)) for 5 min at
room temperature, and a 32P-radiolabeled double-stranded CRE oli-
godeoxynucleotide probe was added to the reaction mixture. After a
20-min incubation at room temperature, each sample was resolved on
a 5% non-denaturing polyacrylamide gel in 0.5UTBE bu¡er, with
subsequent autoradiography as described elsewhere [24]. Competition
experiments were performed by prior incubation of the various pro-
teins with a non-radiolabeled competitor oligodeoxynucleotide for 20
min. The sequence of the DNA probe was 5P-AGCTCCCGT-
GACGTCACCCG-3P, corresponding to the CRE that extends from
nucleotide (nt) 3177 to nt 3162 in the promoter of the gene for
¢bronectin from mouse [29]. To examine the formation of a JDP2
heterodimer with ATF-2, the EMSA using in vitro translated ATF-2
and JDP2 was performed as described elsewhere [32].
2.8. Determination of the nucleotide sequence of JDP2 cDNA
The nucleotide sequence of both strands of JDP2 cDNA was de-
termined with a BigDye1 Terminator Cycle Sequencing kit (PE-Ap-
plied Biosystems Inc., Foster City, CA, USA). Nucleotide and de-
duced amino acid sequences were analyzed by a BLAST search
[30,31] of the SwissProt and GenBank databases.
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3. Results
3.1. Isolation of proteins that interact with ATF-2
To isolate proteins that interacted with the ATF-2, we
screened a mouse 11-day embryo cDNA library using the
yeast two-hybrid system with cDNA for ATF-2 as the bait.
We screened approximately 1U106 yeast transformants and
identi¢ed 150 colonies by growth on selection medium that
lacked histidine. Sixteen of these clones were scored as pos-
itive for L-galactosidase activity and we determined the nucle-
otide sequences of these clones. Among the clones identi¢ed,
clone 6 was selected for further characterization. As shown in
Fig. 1A, the yeast transformant that coexpressed pACT2-
clone 6 and pGBT9-ATF-2 grew on medium that lacked his-
tidine (left panel). Activation of the LacZ reporter gene was
determined by measuring L-galactosidase activity (right pan-
el). When expressed alone, neither pGBT9-ATF-2 nor
pACT2-clone 6 transactivated the LacZ reporter gene. By
contrast, coexpression of the two plasmids resulted in strong
expression of the reporter gene, indicating that the product of
clone 6 and ATF-2 had interacted directly or indirectly in the
yeast cells. Subsequent 5P-RACE led to the complete identi-
¢cation of the 5P-end sequences that encompassed the initia-
tion codon and 137 bp of the 5P-untranslated region. The
complete cDNA sequence of clone 6 (GenBank accession
number AB034697) included 1.5-kb nucleotides and contained
an open reading frame of 498 bp that corresponded to a poly-
peptide of 163 amino acids with a basic leucine zipper (bZIP)
motif at its carboxyl-terminus.
A BLAST search revealed that the polypeptide that was
encoded by clone 6 exhibited 99% identity with rat JDP2,
which was initially isolated as a c-jun repressor by Aronheim
et al. [32], and 96% alignment with human JDP2 deduced
from a human genomic DNA sequence (GenBank accession
number: AC009363 and AF111167; Fig. 1B). These observa-
tions suggest that clone 6 encodes the mouse homolog of
JDP2. Sequence analysis also showed that no changes were
presented in the critical position a/d and e/g in the K-helix of
the bZIP domain that controls dimerization speci¢city (Fig.
1B) [33,34]. Furthermore, the comparison of the amino acid
sequence revealed that JDP2 was approximately 53% homol-
ogous to ATF3, a transcriptional repressor, and its bZIP re-
gion was 75% homologous to that of ATF3 [35].
3.2. Binding of JDP2 to ATF-2 in vitro and in vivo
To con¢rm the interaction between the putative polypeptide
JDP2 and ATF-2, we performed a binding study to explore
the requirements for formation of a heterodimer between
JDP2 and ATF-2. Three GST fusion proteins were synthe-
sized and immobilized on glutathione-Sepharose beads. The
beads were then incubated with reticulocyte lysates that con-
tained [35S]methionine radiolabeled ATF-2 or JDP2 and, after
extensive washing, the bound proteins were fractionated by
SDS^PAGE. Fig. 2A shows that JDP2 bound to GST-ATF-
2 beads and vice versa. However, JDP2 did not bind to the
GST beads. We next examined the interaction between ATF-2
and JDP2 in vivo (Fig. 2B). Two plasmids for ATF-2, or for
histidine-tagged JDP2, were cotransfected into F9 cells and
histidine-tagged JDP2 protein was puri¢ed with TALON
beads. Then the eluted proteins were analyzed by Western
blotting with antibodies speci¢c for ATF-2. ATF-2 was co-
puri¢ed with histidine-tagged JDP2 (lane 2), but not with
histidine alone as a control (lane 1). A similar complementary
experiment was performed and con¢rmed the results described
above (data not shown). These results suggested that JDP2
interacted speci¢cally with ATF-2 both in vitro and in vivo.
To determine further the interaction domain between JDP2
and ATF-2, we used mutant JDP2 and ATF-2 for the binding
assay (Fig. 2C). Whereas the truncation mutants contain-
ing the bZIP domain, ATF-2bZIP and JDP2bZIP, bound
Fig. 1. Isolation of ATF-2-interacting proteins. (A) Isolation of
mouse JDP2 as the partner of ATF-2. The GAL4AD-tagged mouse
11-day embryo cDNA library was used to cotransform HF7C yeast
cells together with pGBT9-ATF-2, in which the cDNA for the
DNA-binding domain (DBD) of GAL4 was fused to ATF-2 cDNA.
Yeast HF7C cells contained HIS3 and LacZ reporter genes under
the control of the UAS of GAL4. Left panel: transformants coex-
pressing the pACT2-clone 6 and pGBT9-ATF-2 that grew on me-
dium lacking histidine, as a result of expression of the HIS3 report-
er via interaction of ATF-2 and the protein encoded by clone 6.
Negative controls are also shown. Right panel: L-galactosidase ac-
tivity in HF7C yeast cells that expressed GAL4AD (pACT2) or the
GAL4AD-clone 6 (pACT2-clone 6) fusion protein in the presence
of GAL4DBD (pGBT9) or GAL4DBD-ATF-2 (pGBT9-ATF-2). (B)
Comparison of the amino acid sequences among various JDP2 pro-
teins. Identical sequences of three JDP2 proteins are shown by black
boxes and two of them were indicated by gray boxes. The sequence
of human JDP2 was deduced from the sequences of two genomic
DNAs. a, d, e and g correspond to the positions of amino acid resi-
dues in K-helix of bZIP region, as previously demonstrated in the
case of c-Jun and c-Fos [33,34].
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each other as e⁄ciently as the wild-type, the mutant
JDP2bZIP(L34V), in which the third and the fourth leucine
in the bZIP region were changed to valine, failed to interact
with ATF-2bZIP. These results imply that JDP2 and ATF-2
interact via their own bZIP domain.
3.3. Expression of JDP2 transcripts
We examined the tissue distribution of JDP2 transcripts
using a mouse MTN blot (Fig. 3A). Transcripts were identi-
¢ed in all tissues examined, albeit at di¡erent levels. Interest-
ingly, we detected at least 10 mRNAs, with lengths of 7.0 kb,
4.4 kb, 4.0 kb, 3.0 kb, 2.6 kb, 2.4 kb, 2.0 kb, 1.5 kb, 1.3 kb
and 1.0 kb, respectively. The levels of the mRNAs in heart,
brain, liver, kidney and testis were higher than in other tis-
sues. The levels of JDP2 mRNA in spleen, lung and skeletal
muscle were very low and the bands were only revealed after
extended exposure (Fig. 3B). The 3.0-kb and 2.4-kb tran-
scripts were most abundant in heart and brain tissue, respec-
tively. In the liver and kidney, the 4.4-kb transcript was pre-
dominant, but the 3.0-kb and 2.4-kb mRNAs were also
present at high levels. However, in testis, transcripts of 7.0
kb, 4.0 kb, 2.6 kb, 2.0 kb and 1.0 kb were detected as the
major transcripts. Longer exposure revealed that transcripts
of 3.0 kb, 2.0 kb and 1.5 kb were the major species in spleen,
while transcripts of 4.4 kb, 3.0 kb and 2.0 kb were detected in
the lung. The 7.0-kb, 2.6-kb and 1.3-kb transcripts were also
detected in skeletal muscle. We also examined the pattern of
expression of JDP2 in mouse embryos using mouse embryo
MTN blots (Fig. 3C), and we detected mRNAs of 7.0 kb, 3.0
kb and 1.5 kb. Only the transcript of 3.0 kb was expressed in
7-day embryos and the level was very low, whereas transcripts
of 1.5 kb and 3.0 kb were found in 11-day and 15-day em-
bryos, respectively. All three transcripts were detected in 17-
day embryos.
3.4. Repression by JDP2 of the CRE-dependent transcription
that is mediated by ATF-2
To investigate the role of mouse JDP2 in the regulation of
the transcriptional activity of ATF-2, we cotransfected
NIH3T3 cells with various combinations of a CRE/tk-CAT
reporter construct, a plasmid that encoded JDP2 and a plas-
mid that encoded ATF-2, and monitored the CRE-mediated
reporter activity in the presence and in the absence of JDP2
and ATF-2. As expected, ATF-2 by itself activated the tran-
scription of the CRE/tk-CAT reporter gene (Fig. 4A). How-
ever, expression of JDP2 suppressed the ability of ATF-2 to
activate the CRE/tk-CAT reporter gene (Fig. 4A). In a con-
trol experiment, we used the mCRE/tk-CAT construct, in
C
Fig. 2. Interaction between ATF-2 and JDP2. (A) Selective interac-
tions between ATF-2 and JDP2 in vitro. In vitro translated
[35S]methionine-labeled ATF-2 (IVT-ATF-2) was incubated with
GST-JDP2 (GST-JDP2) or GST (left panel) and vice versa (right
panel). The amount of sample loaded in each input lane was equal
to approximately 20% of the in vitro translated protein used for the
binding assay. Bound ATF-2 and JDP2 are indicated by arrowheads
and the mobilities and molecular masses of marker proteins are also
shown. (B) Binding of JDP2 to ATF-2 in vivo. Whole cell lysates
were prepared from F9 cells that had been cotransfected with an
ATF-2 expression vector (pECE-ATF-2) and the plasmid (pcDNA4-
JDP2) to express histidine-tagged JDP2 (lane 2), or empty vector
(lane 1), and the histidine-tagged JDP2 were separated with TA-
LON resins. The co-puri¢ed proteins were analyzed by Western
blotting with antibodies speci¢c for ATF-2. In lane 3, an aliquot of
the cell lysates (approximately 5%) was directly used for Western
blotting. (C) Interaction domain of ATF-2 and JDP2. In vitro
translated [35S]methionine-labeled ATF-2/bZIP (IVT-ATF-2/bZIP)
containing the bZIP domain of ATF-2 was incubated with GST-
JDP2/bZIP containing the bZIP region of JDP2 (lane 3), GST-
JDP2/bZIP(L34V), in which the third and the fourth leucine in the
bZIP domain were changed to valine (lane 4), or GST (lane 2).
Bound ATF-2/bZIP is indicated by an arrowhead and the molecular
masses of marker proteins are also shown.
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which two nucleotides in the CRE had been changed. The
expression of JDP2 had no e¡ect on the ATF-2-mediated
transcription of this altered mCRE/tk-CAT reporter gene
(Fig. 4B). The results demonstrated that JDP2 speci¢cally re-
pressed the CRE-dependent transcription of the reporter con-
struct that was mediated by ATF-2, with a decrease in the
level of expression of the reporter of approximately 10-fold.
To examine the contribution of JDP2 to ATF-2-mediated
transactivation in further detail, we studied the e¡ect of
over-expression of JDP2 on a CRE-dependent reporter gene.
As shown in Fig. 4C, over-expression of JDP2 suppressed
expression of the reporter gene in a dose-dependent manner.
By contrast, the coexpressing empty vector did not a¡ect the
reporter activity that was mediated by ATF-2.
3.5. DNA-binding activity of JDP2 in vitro
We examined the DNA-binding activity of JDP2 in vitro by
an EMSA. GST-fused JDP2 and GST-fused ATF-2 were pro-
duced in E. coli and puri¢ed on a column of glutathione-
Sepharose. The formation of DNA^protein complexes with
a CRE probe in vitro was con¢rmed by the supershifting of
bands that occurred when antibodies against ATF-2 or
against GST were included in the reaction mixture. As shown
in Fig. 5A, GST-fused JDP2 generated two distinct bands
(lane 2) and the mobility of both bands was reduced, or the
bands disappeared when antibodies speci¢c for JDP2 or GST
were included (data not shown). The rapidly migrating band
might represent the complex of the DNA probe with GST-
JDP2 that had lost the amino-terminal region of GST-JDP2
but still retained the intact carboxy-terminal region of GST-
JDP2. GST by itself did not bind to the CRE probe (lane 1).
The non-radiolabeled oligodeoxynucleotide that corresponded
to CRE competed for binding to the GST-JDP2 fusion pro-
tein (lane 3). By contrast, a mutated oligodeoxynucleotide did
not compete with radiolabeled CRE for binding to GST-JDP2
(lane 4). In similar analyses, we also detected the complex of
the DNA probe with the GST-ATF-2 homodimer in vitro. We
observed competition by non-radiolabeled CRE but not by
non-radiolabeled mutated CRE (lanes 5^7).
To our surprise, we did not detect a signi¢cant DNA^pro-
tein complex with the GST-ATF-2/GST-JDP2 heterodimer in
the presence of the CRE probe DNA (data not shown). It
could be reasoned that the absence of signi¢cant retarded
GST-ATF-2/GST-JDP2 complex is due to the structural hin-
drance of GST fusion. Thus, we next examined the formation
of the JDP2/ATF-2 heterodimer by in vitro translated pro-
teins. As shown in Fig. 5B, each homodimer of in vitro trans-
lated ATF-2 and of JDP2 bound to the CRE probe (lanes 2
and 3), but reticulocyte lysate failed to bind the CRE probe
Fig. 3. Northern blotting analysis of JDP2 transcripts. (A) Tran-
scripts on a mouse MTN blot ¢lter were allowed to hybridize with
a 1.5-kb 32P-radiolabeled fragment of JDP2 cDNA. The radioactive
probe was washed from the blot after autoradiography and the blot
was reprobed with cDNA for L-actin. (B) The transcripts on a
mouse MTN blot were allowed to hybridize with the JDP2 cDNA
probe as indicated in (A) but exposure was extended for another
8 h. (C) The transcripts on a mouse embryo MTN blot were al-
lowed to hybridize with the JDP2 cDNA probe. The transcripts on
the ¢lter were rehybridized with a cDNA for L-actin after removal
of the JDP2 cDNA probe from the ¢lter. The sizes of JDP2 tran-
scripts are indicated on the left.
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by itself. The JDP2 also formed a heterodimer with the ATF-2
(lane 4) in the presence of the CRE probe, with a molecular
weight di¡erent from that attributed to the ATF-2 or JDP2
homodimer. These data demonstrate that JDP2 binds to CRE
as a homodimer or heterodimer with ATF-2.
4. Discussion
We report here the identi¢cation of mouse JDP2 as the
interaction partner of ATF-2 in a yeast two-hybrid screening
test. We also demonstrated that JDP2 negatively regulates the
transcription of a CRE-dependent promoter that is mediated
by ATF-2. In a binding assay in vitro (Fig. 2A), more than
10% of the input ATF-2 protein was associated with JDP2
and vice versa. In a pull-down assay in vivo, ATF-2 and
histidine-tagged JDP2 were co-puri¢ed by TALON resins
(Fig. 2B). Moreover, using mutant ATF-2 and JDP2, we de-
termined the interaction domain between JDP2 and ATF-2 as
their bZIP region. The DNA-binding assay also showed that
JDP2 makes a heterodimer with ATF-2, although its forma-
tion is not a predominant one. A histidine-tagged derivative of
JDP2 was localized in the nuclei of mouse ¢broblasts and
embryonal carcinoma cells, as is ATF-2 (data not shown).
These results demonstrated that JDP2 interacted with ATF-
2 both in vitro and in vivo in a classical way.
JDP2 transcripts were expressed in all mouse tissues exam-
ined, albeit at di¡erent levels. At least 10 transcripts were
identi¢ed and abundant expression of JDP2 mRNAs was de-
tected in the heart, brain, liver, kidney and testis, with less
abundant expression in the spleen, lung and skeletal muscle.
In each case, transcripts of di¡erent sizes were expressed.
Southern blotting analysis indicated that JDP2 is encoded
by a single-copy gene in the mouse genome (data not shown).
It remains to be determined how the various transcripts are
generated from the single gene. It is possible that alternative
splicing might be responsible for this phenomenon. The level
of JDP2 transcripts increased during embryonic development.
Moreover, sequence analysis revealed very high conservation
between the human and the rodent JDP2 proteins (Fig. 1B).
These results imply that the expression of JDP2 is important
or essential for development of the embryo, as well as for
maintaining normal structure and/or function.
We examined the role of JDP2 in regulating the transcrip-
tional activity of ATF-2. As expected, ATF-2 enhanced the
expression of the CRE/tk-CAT reporter gene. Simultaneous
expression of JDP2 repressed such expression. Aronhein et al.
[32] reported that JDP2 repressed the activity of c-Jun to
stimulate a jun-luciferase reporter and that it also repressed
activation of the reporter construct by a combination of c-Jun
C
Fig. 4. JDP2-mediated e¡ects on the transcriptional activity of
ATF-2. NIH3T3 cells were cotransfected with (A) a CRE/tk-CAT
reporter (0.2 Wg) or (B) a mutant CRE/tk-CAT reporter (0.2 Wg) to-
gether with either the empty vector or expression vectors for JDP2
and ATF-2 (pcDNA4-JDP2, pECE-ATF-2). At 24 h after transfec-
tion, cells were collected and CAT activity was determined. The
data represent the means þ S.E.M. of results of three independent
experiments, with the relative CAT activity for the wild-type CRE/
tk-CAT reporter alone being normalized to 1.0. Note the di¡erent
scales in (A) and (B). (C) The details of the experiment corre-
sponded to those in (A) but increasing amounts of the expression
vector that encodes JDP2, or the empty vector, were used.
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and c-Fos. Here we observed similar suppression of the ATF-
2-dependent transcription of a CRE-controlled reporter by
JDP2, as shown in Fig. 4.
The DNA-binding study indicated that JDP2 formed a sta-
ble homodimer, or a weak heterodimer, with ATF-2 and
bound to CRE (Fig. 5). Aronhein et al. [32] reported that
JDP2 formed a strong heterodimer with c-Jun in the presence
of TRE, thereby enhancing the DNA-binding activity of c-
Jun. We do not know the exact reasons for this di¡erence. It
should be considered that the di¡erential DNA-binding a⁄n-
ity of JDP2 in homodimers or heterodimers might depend on
the partner in the dimerization and on the DNA sequence
involved in the regulation of transcription. Aronhein et al.
[32] also proposed that JDP2 might repress the TRE-depen-
dent transcriptional activity of c-Jun by forming a c-Jun/JDP2
heterodimer, that competes with activators for binding to c-
Jun. Alternatively, JDP2 also enhances the binding of c-Jun to
TRE, thereby providing further inhibition by competition
with active heterodimers for binding to the TRE. Because
JDP2 did not make a strong heterodimer with ATF-2, as
with c-Jun, it seems likely that neither of the above two mech-
anisms is the major one, by which JDP2 might repress ATF-2-
mediated CRE-controlled transcription. One possible mecha-
nism might be that JDP2 represses ATF-2-mediated transcrip-
tional activity by recruiting some inhibitory factors, such as
histone deacetyltransferases, to the CRE promoter. Chen et
al. [36] reported that ATF3 represses transcription from the
promoters with ATF sites by stabilizing the inhibitory co-fac-
tors at the promoter. The high sequence identity between
JDP2 and ATF3 might suggest the similar mechanisms of
the transcriptional repression. These problems remained to
be solved.
The results of DNA-binding and reporter assays suggest
that JDP2, a ubiquitously expressed bZIP protein, plays a
key role in the regulation, not only of Ap-1/TRE-dependent
transcription, but also of CRE-dependent transcription. Thus,
JDP2 might be a general repressor of transcription, that is
related to the Jun/Fos/ATF-2 family. The fact that JDP2 is
a repressor of ATF-2 implies that it might inhibit RA-medi-
ated transcription of the c-jun gene in F9 cells [21]. Our initial
purpose was to isolate a c-jun activator within the DRF com-
plexes [21], so we are now not only studying the e¡ect of
JDP2 on the di¡erentiation of F9 cells, but also analyzing
which one, among the proteins isolated as ATF-2 interaction
partners in this study, was included in the DRF complexes
and activates the c-jun transcription in F9 cells.
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